FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2603969886> ?p ?o ?g. }

• W2603969886 endingPage "549" @default.
• W2603969886 startingPage "549" @default.
• W2603969886 abstract "<h3>Importance</h3> Intravenous thrombolysis (IVT) followed by mechanical thrombectomy (MT) is recommended to treat acute ischemic stroke (AIS) with a large vessel occlusion (LVO). Most hospitals do not have on-site MT facilities, and most patients need to be transferred secondarily after IVT (drip and ship), which may have an effect on the neurologic outcome. <h3>Objective</h3> To compare the functional independence at 3 months between patients treated under the drip-and-ship paradigm and those treated on site (mothership). <h3>Design, Setting, and Participants</h3> This study used a prospectively gathered registry of patients with AIS to select patients admitted through the Saint-Antoine and Tenon (drip and ship) or the Fondation Rothschild (mothership) hospitals from January 1, 2013, through April 30, 2016. The study included patients older than 18 years treated with bridging therapy for AIS with LVO of the anterior circulation. Among the 159 patients who received MT at the mothership, 100 had been transferred after IVT from the drip-and-ship hospitals and 59 had received IVT on site. <h3>Main Outcomes and Measures</h3> The main outcome was 3-month functional independence (modified Rankin scale score ≤2). Both groups were compared using a multivariate linear model, including variables that were significantly different in the 2 groups. <h3>Results</h3> During the study period, 497 patients were hospitalized at the drip-and-ship and mothership hospitals for an AIS eligible to reperfusion therapy; 11 patients had a basilar artery occlusion and were excluded, leaving 100 patients in the drip-and-ship group (mean age, 73 years; age range, 60-81 years; 57 men [57.0%]) and 59 in the mothership group (mean age, 70 years; age range, 58-82 years; 29 men [49.2%]). The proportion of patients with a favorable neurologic outcome at 3 months was similar in both groups (drip and ship, 61 [61.0%]; mothership, 30 [50.8%];<i>P</i> = .26), even after adjusting the analysis for the baseline National Institutes of Health Stroke Scale score, diffusion-weighted imaging Alberta Stroke Program Early Computed Tomography Score, and general anesthesia (<i>P</i> = .82). Patients had less severe conditions in the drip-and-ship group (median baseline National Institutes of Health Stroke Scale score, 15 vs 17 [<i>P</i> = .03]; median diffusion-weighted imaging Alberta Stroke Program Early Computed Tomography Score, 7.5 vs 7 [<i>P</i> = .05]). Process times were longer in the drip-and-ship group (onset-to-needle time, 150 vs 135 minutes; onset-to-puncture time, 248 vs 189 minutes; and onset-to-recanalization time, 297 vs 240 minutes;<i>P</i> < .001). Both groups were similar in terms of substantial recanalization (Thrombolysis in Cerebral Ischemia scores 2B to 3; drip and ship, 84 [84.0%]; mothership, 47 [79.7%];<i>P</i> = .49) and symptomatic hemorrhagic transformation (drip and ship, 2 [2.0%]; mothership, 2 [3.4%];<i>P</i> = .63). <h3>Conclusions and Relevance</h3> This study found that patients treated under the drip-and-ship paradigm also benefit from bridging therapy, with no statistically significant difference compared with those treated directly in a comprehensive stroke center." @default.
• W2603969886 created "2017-04-07" @default.
• W2603969886 creator A5027004580 @default.
• W2603969886 creator A5046045433 @default.
• W2603969886 creator A5057527734 @default.
• W2603969886 creator A5059668536 @default.
• W2603969886 creator A5065425860 @default.
• W2603969886 creator A5081881763 @default.
• W2603969886 creator A5086707201 @default.
• W2603969886 date "2017-05-01" @default.
• W2603969886 modified "2023-10-18" @default.
• W2603969886 title "Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke" @default.
• W2603969886 cites W132472807 @default.
• W2603969886 cites W1986233455 @default.
• W2603969886 cites W1994844876 @default.
• W2603969886 cites W1996802760 @default.
• W2603969886 cites W1998128950 @default.
• W2603969886 cites W2003575106 @default.
• W2603969886 cites W2014508267 @default.
• W2603969886 cites W2014796100 @default.
• W2603969886 cites W2020129136 @default.
• W2603969886 cites W2029618616 @default.
• W2603969886 cites W2037399775 @default.
• W2603969886 cites W2050880768 @default.
• W2603969886 cites W2064482480 @default.
• W2603969886 cites W2067395123 @default.
• W2603969886 cites W2081613681 @default.
• W2603969886 cites W2086809027 @default.
• W2603969886 cites W2099706007 @default.
• W2603969886 cites W2102447759 @default.
• W2603969886 cites W2110337529 @default.
• W2603969886 cites W2111559905 @default.
• W2603969886 cites W2119542322 @default.
• W2603969886 cites W2138595885 @default.
• W2603969886 cites W2139621750 @default.
• W2603969886 cites W2143237216 @default.
• W2603969886 cites W2151475645 @default.
• W2603969886 cites W2159233098 @default.
• W2603969886 cites W2164763924 @default.
• W2603969886 cites W2171058244 @default.
• W2603969886 cites W2178466040 @default.
• W2603969886 cites W2198398064 @default.
• W2603969886 cites W2269034170 @default.
• W2603969886 cites W2303559484 @default.
• W2603969886 cites W2304875530 @default.
• W2603969886 cites W2324357454 @default.
• W2603969886 cites W2340148706 @default.
• W2603969886 cites W2340716980 @default.
• W2603969886 cites W2344625429 @default.
• W2603969886 cites W2347089146 @default.
• W2603969886 cites W2399155639 @default.
• W2603969886 cites W2467872891 @default.
• W2603969886 cites W2469502808 @default.
• W2603969886 cites W2471109711 @default.
• W2603969886 cites W2501634750 @default.
• W2603969886 cites W2504955061 @default.
• W2603969886 cites W2511388967 @default.
• W2603969886 cites W2516637150 @default.
• W2603969886 cites W2526978419 @default.
• W2603969886 cites W2544578848 @default.
• W2603969886 cites W4229005747 @default.
• W2603969886 doi "https://doi.org/10.1001/jamaneurol.2016.5823" @default.
• W2603969886 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5822198" @default.
• W2603969886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28319240" @default.
• W2603969886 hasPublicationYear "2017" @default.
• W2603969886 type Work @default.
• W2603969886 sameAs 2603969886 @default.
• W2603969886 citedByCount "99" @default.
• W2603969886 countsByYear W26039698862017 @default.
• W2603969886 countsByYear W26039698862018 @default.
• W2603969886 countsByYear W26039698862019 @default.
• W2603969886 countsByYear W26039698862020 @default.
• W2603969886 countsByYear W26039698862021 @default.
• W2603969886 countsByYear W26039698862022 @default.
• W2603969886 countsByYear W26039698862023 @default.
• W2603969886 crossrefType "journal-article" @default.
• W2603969886 hasAuthorship W2603969886A5027004580 @default.
• W2603969886 hasAuthorship W2603969886A5046045433 @default.
• W2603969886 hasAuthorship W2603969886A5057527734 @default.
• W2603969886 hasAuthorship W2603969886A5059668536 @default.
• W2603969886 hasAuthorship W2603969886A5065425860 @default.
• W2603969886 hasAuthorship W2603969886A5081881763 @default.
• W2603969886 hasAuthorship W2603969886A5086707201 @default.
• W2603969886 hasBestOaLocation W26039698862 @default.
• W2603969886 hasConcept C126322002 @default.
• W2603969886 hasConcept C127413603 @default.
• W2603969886 hasConcept C141071460 @default.
• W2603969886 hasConcept C2776268601 @default.
• W2603969886 hasConcept C2779581417 @default.
• W2603969886 hasConcept C2780645631 @default.
• W2603969886 hasConcept C500558357 @default.
• W2603969886 hasConcept C71924100 @default.
• W2603969886 hasConcept C78519656 @default.
• W2603969886 hasConceptScore W2603969886C126322002 @default.
• W2603969886 hasConceptScore W2603969886C127413603 @default.
• W2603969886 hasConceptScore W2603969886C141071460 @default.
• W2603969886 hasConceptScore W2603969886C2776268601 @default.
• W2603969886 hasConceptScore W2603969886C2779581417 @default.

• next